Chronic Toll-like Receptor Ligation and Hematopoietic Stem Cell Aging
慢性Toll样受体结扎与造血干细胞衰老
基本信息
- 批准号:7918110
- 负责人:
- 金额:$ 2.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-24 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAftercareAgeAgingB-LymphocytesBehaviorBiological AssayBlood CellsBone MarrowBone Marrow Stem CellBromodeoxyuridineCD34 geneCell AgingCell CountCell CycleCell LineageCell physiologyCellular StressChronicClinicalColorDendritic CellsDetectionDiseaseDyesElderlyEngraftmentEnsureEnvironmentExhibitsExposure toFlow CytometryFutureGenesHealthcareHematopoieticHematopoietic SystemHematopoietic stem cellsHomeostasisHybridsITGAM geneImmuneImmune systemIn SituInfectionInflammatoryIntraperitoneal InjectionsInvestigationKnockout MiceLaboratoriesLeadLifeLigandsLigationLightLong-Term EffectsLongevityLymphoidMacrophage-1 AntigenMarrowMeasurementMediatingModelingMolecularMusMyelogenousMyelopoiesisNatural ImmunityOutputParvovirusPathway interactionsPatientsPhenotypePhysiologyPopulationPopulation DynamicsPopulation SizesPremature aging syndromeProcessPublishingPyronineRecoveryRegenerative MedicineReportingResearchReverse Transcriptase Polymerase Chain ReactionSamplingSideSignal TransductionStaining methodStainsStem cellsStressSurfaceSystemTaxesTechniquesTelomeraseTestingTimeTissuesToll-like receptorsTranslatingTransplantationWestern Blottingabstractingage relatedagedbasecell agecell behaviorclinical applicationexhaustionfitnessin vivo Modelinterestmicrobialnovelnovel strategiesnovel therapeutic interventionpathogenprematureprogenitorreconstitutionresearch studyresponseself-renewalstem cell differentiation
项目摘要
DESCRIPTION (provided by applicant): Whereas the hematopoietic system is the most characterized of any stem-cell driven tissue; and given the astronomical output requirements of hematopoietic stem cells (HSC) over a lifespan, this system has become an optimal target for studies on aging and regenerative medicine. In light of the recent discovery that microbial toll-like receptor (TLR) ligands can directly impact HSC homeostasis, research aimed at protecting HSC from the stress of infection is becoming increasingly relevant. Here we introduce a new experimental approach to determine whether chronic infection-related conditions hasten HSC aging. Through the use of an established model, we are primed to answer new questions concerning the effects of chronic TLR ligation on the aging and long-term physiology of HSC. The experimental plan is outlined by two Specific Aims, which are:(1) Determine the numbers, phenotype, differentiation potential, and cell cycle status of HSC and primitive progenitors in chronically-stimulated marrow, and (2) Rigorously test the integrity of HSC recovered from chronic TLR ligand-stimulated mice. Our strategy consists of investigating both the immediate and long-term effects of chronic TLR ligation on HSC aging. Daily intraperitoneal injections with LPS or Pam3CSK4 will be used to model chronic infection. We will determine if chronic TLR stimulation alters HSC integrity by evaluating bone marrow population dynamics, surface phenotypes, and progenitor cell cycle status during treatment, and throughout age-accelerating conditions. Multi-color flow cytometry and molecular assays such as western blot and RT-PCR will reveal whether chronic TLR stimulation induces lineage biases in aging HSC. Novel application of F1 hybrid recipients will also allow precise quantification of HSC fitness during serial transplants. Well-defined culture systems will further assess HSC differentiation potential. Chronic infections require significant efforts in patient treatment each year. Whether chronic infection-related deficiencies lead to accelerated HSC aging is an important question we are poised to address in the studies outlined here. Diminished immune system function due to exhaustion of bone marrow stem cells is a common consequence of aging. Because of this, even mild infections pose a serious threat to elderly or immune-compromised patients. The studies outlined here present a new approach for identifying potential means of protecting bone marrow stem cells from the ravages of infection and aging. This information may lead to clinical applications that prolong life in aged or immune-compromised patients by preserving the integrity of the immune system during challenging circumstances.
描述(由申请人提供):鉴于造血系统是任何干细胞驱动的组织中最具特征的;并且考虑到造血干细胞(HSC)在整个生命周期中的天文输出需求,该系统已成为衰老和再生医学研究的最佳目标。鉴于最近发现微生物toll样受体(TLR)配体可以直接影响HSC稳态,旨在保护HSC免受感染应激的研究变得越来越相关。在这里,我们介绍了一种新的实验方法,以确定是否慢性感染相关的条件加速HSC老化。通过使用已建立的模型,我们准备回答有关慢性TLR结扎对HSC衰老和长期生理学影响的新问题。实验计划由两个特定目的概述,它们是:(1)确定慢性刺激骨髓中HSC和原始祖细胞的数量、表型、分化潜能和细胞周期状态,以及(2)严格测试从慢性TLR配体刺激小鼠中回收的HSC的完整性。我们的策略包括研究慢性TLR结扎对HSC衰老的即时和长期影响。每天腹膜内注射LPS或Pam 3CSK 4将用于模拟慢性感染。我们将通过评估治疗期间和整个年龄加速条件下的骨髓群体动力学、表面表型和祖细胞周期状态来确定慢性TLR刺激是否改变HSC的完整性。多色流式细胞术和分子检测如蛋白质印迹和RT-PCR将揭示慢性TLR刺激是否诱导衰老HSC的谱系偏好。F1杂交受体的新应用也将允许在连续移植期间精确定量HSC适应性。明确的培养系统将进一步评估HSC分化潜力。慢性感染每年都需要在患者治疗方面做出重大努力。慢性感染相关的缺陷是否会导致HSC加速老化是我们在这里概述的研究中准备解决的一个重要问题。由于骨髓干细胞耗尽而导致的免疫系统功能下降是衰老的常见后果。因此,即使是轻微的感染也会对老年人或免疫功能低下的患者构成严重威胁。这里概述的研究提出了一种新的方法,用于确定保护骨髓干细胞免受感染和衰老破坏的潜在方法。这一信息可能导致临床应用,通过在挑战性环境中保持免疫系统的完整性来延长老年或免疫受损患者的生命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRANDT L ESPLIN其他文献
BRANDT L ESPLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRANDT L ESPLIN', 18)}}的其他基金
Chronic Toll-like Receptor Ligation and Hematopoietic Stem Cell Aging
慢性Toll样受体结扎与造血干细胞衰老
- 批准号:
7696448 - 财政年份:2008
- 资助金额:
$ 2.58万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 2.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 2.58万 - 项目类别:
Operating Grants